The AltiVate Reverse Glenoid System, an important addition to Enovis' industry-leading AltiVate products, received FDA 510(k) clearance in May 2024 for use in reverse shoulder arthroplasty ...

AUSTIN, TX, July 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), a leading innovator in shoulder arthroplasty systems that help improve quality of life and restore movement, introduced today ...

“Our research determined that placing the reverse glenoid baseplate in 0° to 5° of retroversion had the same clinical and radiographic outcomes as patients who had their baseplates placed in 6 ...

AUSTIN, TX, July 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), a leading innovator in shoulder arthroplasty systems that help improve quality of life and restore movement, introduced today ...

RevoMotion significantly expands Anika’s shoulder arthroplasty portfolio and provides a new solution in the over $800 million U.S. reverse shoulder market RevoMotion offers the industry’s ...

The AltiVate Reverse Glenoid System, an important addition to Enovis' industry-leading AltiVate products, received FDA 510(k) clearance in May 2024 for use in reverse shoulder arthroplasty ...

The AltiVate Reverse Glenoid System, an important addition to Enovis' industry-leading AltiVate products, received FDA 510(k) clearance in May 2024 for use in reverse shoulder arthroplasty ...

Enovis ENOV recently introduced the AltiVate Reverse Glenoid System, expanding the glenoid implant offering of the AltiVate Reverse by including modular and augmented baseplates. The new full-range ...